SCHEMBL31322158

SCHEMBL31322158

Cc1ccc(CC2CN(CO)c3ccccc32)cc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HCRTR2 O43614 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 1/20 0.34
CYP2C19 P33261 1/20 0.34
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
GSK3B P49841 1/20 0.34
MAPT P10636 1/20 0.34
THRB P10828 1/20 0.34
OPRK1 P41145 2/20 0.34
USP2 O75604 1/20 0.33
PKM P14618 1/20 0.33
MAPK1 P28482 1/20 0.33
OPRM1 P35372 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31322148 0.87 ESR1 (0.47) ESR1ESR2OPRK1
SCHEMBL13621786 0.86 HDAC3 (0.36) MEN1KMT2APOLBESR1ESR2
SCHEMBL31322144 0.86 HTR6 (0.48) MEN1KMT2AESR1ESR2GSK3B
SCHEMBL31322118 0.83 CCR5 (0.39)
SCHEMBL13632640 0.82 SIRT2 (0.43) LMNAPOLB
SCHEMBL31322157 0.82 L3MBTL1 (0.44) L3MBTL1MEN1KMT2AALDH1A1
SCHEMBL31322121 0.78 CRBN (0.41) MEN1KMT2ALMNAALDH1A1CYP2C19
SCHEMBL13361987 0.70 LMNA (0.44) LMNAALDH1A1ESR2MAPTOPRK1
SCHEMBL5870956 0.67 SIRT2 (0.47) ALDH1A1
SCHEMBL12049115 0.66 OPRK1 (0.35) MEN1KMT2AOPRK1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4483866-A1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF CANCER Makrolife Biotech GmbH (DE) 2025-01-01 EP claimed
EP-4483866-A1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF CANCER Makrolife Biotech GmbH (DE) 2025-01-01 EP disclosed